Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Antigens synthetic oligosaccharide

R. Roy, D. Zanini, S. J. Meunier, and A. Romanowska, Syntheses and antigenic properties of sialic acid-based dendrimers, in P. Kovac, (Ed.), Synthetic Oligosaccharides Indispensable Probes for the Life Sciences, ACS Symp. Sen, 560, 1994, pp. 104-119. [Pg.384]

The specificity of the antiserum raised against the Lea neoglycoprotein (9) was determined by hapten-inhibition studies using synthetic oligosaccharides,72 and derivatives of bovine and horse serum-albumin to which the Lea trisaccharide had been attached.73 On the basis of hapten inhibition of precipitation, this antiserum was shown to be highly specific for the carbohydrate portion of the synthetic antigen,... [Pg.262]

Roy R, Zanini D, Meunier SJ, Romanowska A (1994) Synthesis and antigenic properties of sialic acid based dendrimers. In Kovac P (ed) Synthetic oligosaccharides. Indispensable probes for the life sciences. ACS Symposium Series 560. American Chemical Society, Washington, p 104... [Pg.168]

V. Pozsgay, J. R. Brisson, and H. J. Jennings, Synthetic oligosaccharides related to group B streptococcal polysaccharides. The rhamnotriose moiety of the common antigen, Can. J. Chem., 65 (1987) 2764-2769. [Pg.304]

Wolbach, S.B. Howe, P.R. (1925) Tissue Changes Following Deprivation of Fat-soluble A Vitamin , Journal of Experimental Medicine, 42, 753-78 Wood, E. Feizi, T. (1979) Blood Group I and i Activities of Straight Chain and Branched Synthetic Oligosaccharides Selected to the Precursors of the Major Blood Group Antigens , FEBS Letters, 104, 135-40... [Pg.339]

In November 2003, a glycoconjugate vaccine using a synthetic oligosaccharide was licensed in Cuba to be used in infants. Clinical evidence of their safety and usefulness for prevention of infectious disease in infant population was obtained in eight clinical trials. For the first time, a synthetic carbohydrate antigen became part of a commercially available vaccine. Since then, 34 million doses where produced and used in several countries either as Quimi-Hib or HEBERPENTA. The World Health Organization prequalified Quimi-Hib in 2009, which means the quality of the vaccine was inspected and considered adequate to be used by UNICEF. Recently, a production facility for Quimi-Hib was inaugurated in Jilin province, China. [Pg.591]

See other pages where Antigens synthetic oligosaccharide is mentioned: [Pg.649]    [Pg.230]    [Pg.49]    [Pg.65]    [Pg.100]    [Pg.10]    [Pg.193]    [Pg.193]    [Pg.361]    [Pg.39]    [Pg.181]    [Pg.1827]    [Pg.2673]    [Pg.304]    [Pg.19]    [Pg.162]    [Pg.130]    [Pg.340]    [Pg.206]    [Pg.589]    [Pg.591]    [Pg.604]    [Pg.78]    [Pg.113]    [Pg.113]    [Pg.115]    [Pg.395]    [Pg.25]    [Pg.283]    [Pg.319]    [Pg.11]    [Pg.51]    [Pg.238]    [Pg.203]    [Pg.433]    [Pg.437]    [Pg.261]    [Pg.262]    [Pg.263]    [Pg.264]    [Pg.34]    [Pg.84]    [Pg.90]    [Pg.1]   


SEARCH



Synthetic Oligosaccharides

© 2024 chempedia.info